Sara E. Meyer

1.0k citations

18 papers · 325 indexed · h-index 10

Impact in

Hematology top 10%
- Acute Myeloid Leukemia Research
Cancer Research
- MicroRNA in disease regulation

Papers in ⓘ

Hematology 12
- Acute Myeloid Leukemia Research 11
Cancer Research 6
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2

Co-authors: Susan E. Waltz (4 shared papers)H. Leighton Grimes (7 shared papers)Xiaoting Zhang (1 shared paper)Robert G. Roeder (1 shared paper)SA Khan (1 shared paper)Mitsuhiro Ito (1 shared paper)Qiuping Hu (1 shared paper)Pingping Jiang (1 shared paper)
Journals: Blood (4 papers)Molecular Carcinogenesis (1 paper)Clinical Cancer Research (1 paper)Cancer Discovery (1 paper)Current Opinion in Hematology (1 paper)
Partner nations: United States Canada Netherlands

In The Last Decade

Sara E. Meyer

17 papers receiving 320 citations

Peers

Countries citing papers authored by Sara E. Meyer

Since Specialization

Citations

This map shows the geographic impact of Sara E. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Meyer more than expected).

Fields of papers citing papers by Sara E. Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Meyer. The network helps show where Sara E. Meyer may publish in the future.

Co-authors

The 25 scholars most cited alongside Sara E. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sara E. Meyer Line = papers co-authored together Sara E. Meyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	DNMT3A Haploinsufficiency Transforms FLT3 ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia Cancer Discovery ·Sara E. Meyer, Tingting Qin, David E. Muench, Kohei Masuda, Meenakshi Venkatasubramanian, Emily Orr, Lauren Suarez, Steven D. Gore, Ruud Delwel, Elisabeth Paietta, Martin S. Tallman, Hugo F. Fernández, Ari Melnick, Michelle M. Le Beau, Scott C. Kogan, Nathan Salomonis, María E. Figueroa, H. Leighton Grimes	2016	70
2	Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation Proceedings of the National Academy of Sciences ·Pingping Jiang, Qiuping Hu, Mitsuhiro Ito, Sara E. Meyer, Susan E. Waltz, SA Khan, Robert G. Roeder, Xiaoting Zhang	2010	67
3	Recombineering-based dissection of flanking and paralogous Hox gene functions in mouse reproductive tracts Development ·Anna M. Raines, Mike Adam, Bliss Magella, Sara E. Meyer, H. Leighton Grimes, Sudhansu K. Dey, S. Steven Potter	2013	35
4	The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice Blood ·Cyrus Khandanpour, Joseph Krongold, Judith Schütte, Frederique Bouwman, Lothar Vaßen, Marie‐Claude Gaudreau, Riyan Chen, Fernando J. Calero‐Nieto, Evangelia Diamanti, Rebecca Hannah, Sara E. Meyer, H. Leighton Grimes, Bert A. van der Reijden, Joop H. Jansen, Chandrashekhar V. Patel, Justine Peeters, Bob Löwenberg, Ulrich Dührsen, Berthold Göttgens, Tarik Möröy	2012	33
5	miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential The Journal of Experimental Medicine ·Sara E. Meyer, David E. Muench, Andrew M. Rogers, Tess J Newkold, Emily Orr, Eric O’Brien, John P. Perentesis, John G. Doench, Ashish Lal, Patrick J. Morris, Craig J. Thomas, Judy Lieberman, Edwina McGlinn, Bruce J. Aronow, Nathan Salomonis, H. Leighton Grimes	2018	20
6	The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis Developmental Biology ·Sara E. Meyer, Glendon M. Zinser, William D. Stuart, Peterson Pathrose, Susan E. Waltz	2009	20
7	Krüppel-Like Factor 5 Is Not Required for K-RasG12D Lung Tumorigenesis, but Represses ABCG2 Expression and Is Associated with Better Disease-Specific Survival American Journal Of Pathology ·Sara E. Meyer, Jason R. Hasenstein, Avinash M. Baktula, Chinavenmani S. Velu, Yan Xu, Huajing Wan, Jeffrey A. Whitsett, C. Blake Gilks, H. Leighton Grimes	2010	19
8	Genetic heterogeneity and clonal evolution in acute myeloid leukemia Current Opinion in Hematology ·Jennifer S. Romer-Seibert, Sara E. Meyer	2020	18
9	miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A -Mutant AML Clinical Cancer Research ·Holly A. Gamlen, Jennifer S. Romer-Seibert, Michael Lawler, Amanda M. Versace, Melanie L. Goetz, Yang Feng, Olga A. Guryanova, Neil Palmisiano, Sara E. Meyer	2022	13
10	FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia Leukemia ·Pamela J. Sung, Murugan Selvam, Simone S. Riedel, Hongbo Xie, Katie M. Bryant, Bryan Manning, Gerald Wertheim, Katarzyna Kulej, Lucie Pham, Robert L. Bowman, Jennifer Peresie, Michael J. Nemeth, Ross L. Levine, Benjamin A. Garcia, Sara E. Meyer, Simone Sidoli, Kathrin M. Bernt, Martin Carroll	2024	11
11	The Ron receptor tyrosine kinase is not required for adenoma formation in Apc^Min/+ mice Molecular Carcinogenesis ·Sara E. Meyer, Susan E. Waltz, Kathleen H. Goss	2009	7
12	Chk21100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice Cancer Letters* ·Sara E. Meyer, Belinda E. Peace, El Mustapha Bahassi, Gina M. Kavanaugh, Purnima K. Wagh, Susan B. Robbins, Moying Yin, Susanne I. Wells, Glendon M. Zinser, Peter J. Stambrook, Susan E. Waltz	2010	4
13	The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9 Blood ·Cyrus Khandanpour, Joseph Krongold, Judith Schütte, Frederique Bouwman, Lothar Vaßen, Marie‐Claude Gaudreau, Riyan Chen, Sara E. Meyer, H. Leighton Grimes, Bert A. van der Reijden, Joop H. Jansen, Bob Löwenberg, Justine Peeters, Patel Chandrashekhar, Ulrich Duehrsen, Berthold Goettgens, Tarik Möröy	2011	4
14	MicroRNAs in the midst of myeloid signal transduction Journal of Cellular Physiology ·Sara L. Stoffers, Sara E. Meyer, H. Leighton Grimes	2011	1
15	Differences in Anorectal Manometry Values Among Women With Fecal Incontinence in a Racially, Ethnically, and Socioeconomically Diverse Population Urogynecology ·Whitney L. Clearwater, Sara E. Meyer, Priyanka Kadam Halani	2023	1
16	FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation Blood ·Pamela J. Sung, Simone Sidoli, Simone S. Riedel, Katarzyna Kulej, Hongbo Xie, Bryan Manning, Daniel Tsai, Gerald Wertheim, Benjamin A. García, Sara E. Meyer, Kathrin M. Bernt, Martin Carroll	2021	1
17	Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies Blood ·Linde A. Miles, Robert L. Bowman, Tiffany R. Merlinsky, Aik T. Ooi, Pedro Méndez, Christopher Famulare, Minal Patel, Kelly L. Bolton, Neil Palmisiano, Martin Carroll, Elli Papaemmanuil, Ahmet Zehir, Sara E. Meyer, Aaron D. Viny, Ross L. Levine	2019	1
18	TLR2 agonism suppresses myeloid leukemogenesis by reprogramming leukemia stem cells Blood Advances ·Michael Lawler, Jennifer S. Romer-Seibert, Michael Bowman, Ramkrishna Mitra, Christine M. Eischen, Robert L. Bowman, Sara E. Meyer	2025	0

About Sara E. Meyer

Sara E. Meyer is a scholar working on Hematology, Cancer Research, Immunology, Molecular Biology and Genetics, having authored 18 papers that have together received 325 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer Genomics and Diagnostics (3 papers), Single-cell and spatial transcriptomics (2 papers), MicroRNA in disease regulation (2 papers), Blood disorders and treatments (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Hematology (107 citations), Cancer Research (50 citations), Molecular Biology (223 citations), Immunology (60 citations) and Genetics (79 citations). Sara E. Meyer has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Susan E. Waltz, H. Leighton Grimes, Xiaoting Zhang, Robert G. Roeder, SA Khan, Mitsuhiro Ito, Qiuping Hu, Pingping Jiang, Anna M. Raines and Sudhansu K. Dey. Their work appears in journals such as Blood, Molecular Carcinogenesis, Clinical Cancer Research, Cancer Discovery and Current Opinion in Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact